Nexgel (NXGL) Current Deferred Revenue (2020 - 2025)
Nexgel (NXGL) reported Current Deferred Revenue of $2000.0 for Q4 2025, down 98.88% on a YoY basis from $179000.0 in Q4 2024, and down 98.89% quarter-over-quarter from $180000.0 in Q3 2025.
Nexgel (NXGL) Current Deferred Revenue (2020 - 2025) Analysis & Trends
Nexgel has reported Current Deferred Revenue for 5 years, with the latest figure at $2000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue fell 98.88% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2025 stood at $2000.0 (down 98.88% YoY), and the FY2025 full-year result was $2000.0, down 98.88% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $2000.0, down from $180000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $286000.0 in Q1 2025, with the low at $2000.0 in Q4 2025.
- Historically, Current Deferred Revenue has averaged $138818.2 across 4 years, with a median of $179000.0 in 2024.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue surged 795.0% — and 2025, when it sank 98.88%.
- Nexgel's Current Deferred Revenue stood at $38000.0 in 2021, then slumped by 47.37% to $20000.0 in 2023, then soared by 795.0% to $179000.0 in 2024, then slumped by 98.88% to $2000.0 in 2025.
- The last three Current Deferred Revenue figures came in at $2000.0 (Q4 2025), $180000.0 (Q3 2025), and $180000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 286,000.00 |
| Dec 31, 2024 | 179,000.00 |
| Sep 30, 2024 | 179,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 34,000.00 |
| Mar 31, 2021 | 38,000.00 |
| Dec 31, 2020 | 38,000.00 |